[Federal Register Volume 77, Number 75 (Wednesday, April 18, 2012)]
[Notices]
[Page 23222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-9357]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket T-2-2012]


Foreign-Trade Zone 59, Temporary/Interim Manufacturing Authority, 
Novartis Consumer Health, Inc., (Pharmaceutical Product Manufacturing); 
Notice of Approval

    On January 12, 2012, the Executive Secretary of the Foreign-Trade 
Zones (FTZ) Board filed an application submitted by the Lincoln Foreign 
Trade Zone, Inc., grantee of FTZ 59, requesting temporary/interim 
manufacturing (T/IM) authority, on behalf of Novartis Consumer Health, 
Inc., to manufacture pharmaceutical products under FTZ procedures 
within FTZ 59--Sites 3 and 4, in Lincoln, Nebraska.
    The application was processed in accordance with T/IM procedures, 
as authorized by FTZ Board Orders 1347 (69 FR 52857, 8/30/04) and 1480 
(71 FR 55422, 9/22/06), including notice in the Federal Register 
inviting public comment (77 FR 4758, 1/31/2012). The FTZ staff examiner 
reviewed the application and determined that it meets the criteria for 
approval under T/IM procedures. Pursuant to the authority delegated to 
the FTZ Board Executive Secretary in the above-referenced Board Orders, 
the application is approved, effective this date, until March 27, 2014, 
subject to the FTZ Act and the Board's regulations, including Section 
400.28.

    Dated: March 27, 2012.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2012-9357 Filed 4-17-12; 8:45 am]
BILLING CODE P